Abnormal expression of other H2B genes correlated with poor blood cancer, bladder cancer, breast cancer, colorectal cancer, and lung cancer prognoses (Figures S6A–E). This evidence concerns the gene H2BC21 and hematopoietic and lymphoid system neoplasm.